MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Myasthenia gravis outcomes improve over the years in Japan
by Michela Luciano, PhD on November 21, 2025 at 6:00 pmIn Japan, myasthenia gravis (MG) was associated with an older age at onset and better clinical outcomes in 2018 compared with 2006, according to a new analysis of nationwide survey data spanning 12 years. Data also showed a reduction over time in the doses of corticosteroids, anti-inflammatory steroid medications that can cause serious adverse events The post Myasthenia gravis outcomes improve over the years in Japan appeared first on Myasthenia Gravis News.
- Choosing love, even when my body hesitates
by Sarah Bendiff on November 20, 2025 at 3:00 pmNext week, my boyfriend’s family will come to officially ask for my hand in marriage. Here in Algeria, that’s how engagements start. The groom’s family visits, the parents meet, and the whole thing feels as traditional as it is symbolic. It’s a beautiful ritual, but for me, it comes with an undertone of fear. I’m The post Choosing love, even when my body hesitates appeared first on Myasthenia Gravis News.
- Guest Voice: Studying abroad with MG helped redefine my goals
by Aliya Askhatkyzy on November 19, 2025 at 3:00 pmI was diagnosed with myasthenia gravis (MG) a month before I was supposed to start my bachelor’s program in Amsterdam, Netherlands. I had just finished high school and was dealing with numerous medical tests and doctor appointments when I had to learn how to cope with chronic illness. But what seemed the heaviest of burdens The post Guest Voice: Studying abroad with MG helped redefine my goals appeared first on Myasthenia Gravis News.
- I’m still learning acceptance when MG messes with my day
by Mark Harrington on November 19, 2025 at 3:00 pm“The spirit indeed is willing, but the flesh is weak.” Lately, I’ve felt that this Bible verse could’ve been written about me and my muscles. The last week or so has served as a reminder that fall fatigue is indeed a real phenomenon. This time of year always plays tricks on my myasthenia gravis (MG). The post I’m still learning acceptance when MG messes with my day appeared first on Myasthenia Gravis News.
- Patient registry launches to track myasthenia gravis care
by Margarida Maia, PhD on November 18, 2025 at 1:00 pmThe first patient has been enrolled in a myasthenia gravis (MG) registry to collect clinical information from real-world settings across the U.S., with the aim of better understanding the disease and ultimately improving care. Thermo Fisher Scientific’s newly launched registry is recruiting people with the ocular and generalized types of MG who are treated by The post Patient registry launches to track myasthenia gravis care appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.